Browse the evidence

Type of nutrient and food supplements are essential for a quicker recovery, in addition to their timing and dose.

Focus on specific nutrients and supplements, along with their timing, to enhance recovery.

Time-dependent increases were detected from baseline to week 8 for muscle thickness and strength.

Resistance training leads to significant improvements in muscle thickness and strength over 8 weeks.

The article aims to analyze the roles and practical applications of amino acids in regulating body composition and performance in anaerobic and aerobic sports.

Insights from this analysis can guide training and nutrition strategies for athletes.

SGLT-2 inhibitors and GLP-1 receptor agonists (GLP-1RAs) lead to a decline in body weight ranging from 1.5 to 5 kg.

Practitioners can consider SGLT-2 inhibitors and GLP-1RAs as effective options for weight loss in patients.

Obesity is a major risk factor for the development and progression of type 2 diabetes.

Addressing obesity is crucial for managing type 2 diabetes.

Tirzepatide increases insulin secretion, reduces glucagon release, decreases fasting and postprandial glucose levels, promotes satiety, decreases body weight, and delays gastric emptying.

Tirzepatide can help manage blood sugar levels and weight in patients with type 2 diabetes.

The proportion of participants meeting the criteria for diabetes remission increased from 8.8% at baseline to 32.4% at 24 months.

A structured dietary intervention may enhance the likelihood of diabetes remission in T2DM patients.

Bariatric interventions resulted in reductions in body mass index and hemoglobin A1c.

Bariatric surgery can lead to improvements in metabolic health markers.

The DEF group was in negative nitrogen balance at both 5 and 12 days, indicating insufficient dietary protein.

Insufficient protein intake can lead to negative nitrogen balance during energy deficits.

A higher overall daily protein intake of 1.4-1.6 g/kg/d is recommended for the maintenance and building of muscle mass.

Individuals should aim for a daily protein intake of 1.4-1.6 g/kg to support muscle health.

The LLHR group showed greater strength endurance increases (65 % 1RM) of 8 repetitions (95 % CI (2, 14)).

Lighter load training can effectively improve strength endurance in middle and older adults.

Tirzepatide significantly reduces body mass index, waist circumference, blood pressure, and atherosclerotic cardiovascular disease risk.

Tirzepatide may improve overall cardiometabolic health in non-diabetic obese patients.

A sustained weight loss of 3–5% is likely to result in clinically meaningful reductions in triglycerides, blood glucose, and A1C.

Practitioners should aim for a 3-5% weight loss in patients to improve metabolic health.

Achieving more weight loss (∼10%) will reduce blood pressure, improve LDL cholesterol and HDL cholesterol, and reduce the need for medications required to control cardiometabolic risk.

Practitioners should encourage patients to aim for a 10% weight loss for enhanced cardiometabolic health.

An intensive lifestyle intervention can achieve a 5–10% weight loss and improve sleep apnea quality-of-life indices, achieve cardiometabolic biomarker improvements, and reduce need for medications.

Practitioners should consider intensive lifestyle interventions for diabetic patients to achieve significant health benefits.

Modest weight loss of 2-3% of body weight is recommended to improve therapeutic durability and prevent beta-cell deterioration.

Encouraging patients to achieve modest weight loss can enhance their diabetes management.

The prevalence of metabolic syndrome decreased from 58% at baseline to 19% at follow-up among participants at the first intervention site.

This intervention can significantly reduce the prevalence of metabolic syndrome in similar populations.

Physical activity reduces the risk of developing coronary heart disease, stroke, and type 2 diabetes.

Clinicians should encourage physical activity to reduce the risk of chronic diseases.

A produce prescription program significantly improved HbA1c among low-income patients on Medicaid with poor glycemic control at baseline.

Implementing produce prescription programs may help improve glycemic control in low-income diabetic patients.

HbA1c at 6 months was significantly reduced in the intervention group compared to control.

The intervention may be effective in lowering HbA1c levels in similar patient populations.

Ingestion of a 6.4% carbohydrate-electrolyte solution (CHO) significantly increased plasma glucose oxidation during running (65 ± 20 g.h−1) compared to water (W) (42 ± 16 g.h−1; p < 0.01).

For athletes, consuming carbohydrates before and during exercise can enhance glucose oxidation and potentially improve performance.

The contribution to total carbohydrate oxidation was significantly greater with CHO than W during running (33 ± 4% vs. 23 ± 3%; p < 0.01) and cycling (36 ± 5% vs. 22 ± 3%; p < 0.01).

Athletes should consider carbohydrate solutions to maximize carbohydrate oxidation during endurance activities.

Patients in the semaglutide group experienced greater weight loss compared to the control group (−8.2% vs. −4.6%; P <0.001).

Semaglutide may be effective for weight management in patients post-ablation.

Bariatric surgery effectively improves the management of obesity and inhibits the progression of multiple metabolic diseases.

Bariatric surgery should be considered as a viable option for managing obesity and related metabolic conditions.